Investment
Features
FeesSafety
Academy
More
Pluang+

MySize's Q2 revenue rises 53% to $3.07M as it shifts focus to margin and cash efficiency

Company Fundamentals
14 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

MySize, a fashion tech company, reported a 53% revenue increase in Q2 2026 to $3.07 million and a 57% rise in H1 revenue to $5.46 million, driven by growth in e-commerce and recommerce segments. Despite higher revenue, net loss widened to $1.75 million due to increased expenses and a shift toward lower-margin commerce activities. The company is now prioritizing improving contribution margins, operating leverage, and cash efficiency to build a sustainable financial model. Management aims to leverage its integrated platform to enhance profitability and reduce cash consumption in the second half of 2026.

More News

Wolverine World Wide posts strong growth in Merrell and Saucony, maintains Hold rating amid market risks

Wolverine World Wide posts strong growth in Merrell and Saucony, maintains Hold rating amid market risks

Wolverine World Wide showed strong operational growth in its Merrell and Saucony brands, leading to margin expansion and better future prospects. The stock trades at about 12 times the upper end of its FY26 adjusted earnings guidance, which is consid...

Company Fundamentals
Neutral
4 hours ago
Columbia Banking System declares $0.37 quarterly dividend payable Sept 14, 2026.

Columbia Banking System declares $0.37 quarterly dividend payable Sept 14, 2026.

Columbia Banking System, Inc., the parent company of Columbia Bank, announced a quarterly cash dividend of $0.37 per common share. The dividend will be paid on September 14, 2026, to shareholders recorded as of August 28, 2026. This dividend reflects...

Company Fundamentals
Bullish
4 hours ago
Filament Health to supply psilocybin drug PEX010 for Parkinson's depression clinical trial.

Filament Health to supply psilocybin drug PEX010 for Parkinson's depression clinical trial.

Filament Health, through its parent company Rhelion Life Sciences, will supply its patented psilocybin drug candidate PEX010 to the University Health Network's PSI-PARK clinical trial. This randomized study evaluates psilocybin's effectiveness in tre...

Company Fundamentals
Bullish
4 hours ago
Israel's Bank Leumi to offer Bitcoin trading to 2.5M clients via mobile app in 2027

Israel's Bank Leumi to offer Bitcoin trading to 2.5M clients via mobile app in 2027

Bank Leumi, Israel's largest commercial bank, plans to enable Bitcoin, Ethereum, and Solana trading for its 2.5 million retail clients through its Leumi Trade platform and Pepper app in early 2027. Partnering with Galaxy Digital and custody provider ...

Market News
Bullish
4 hours ago
Applied Materials posts record Q3, raises Q4 revenue forecast to $10.25B, signaling strong growth potential.

Applied Materials posts record Q3, raises Q4 revenue forecast to $10.25B, signaling strong growth potential.

Applied Materials reported record third-quarter results and issued a fourth-quarter revenue guidance of $10.25 billion, significantly exceeding analyst expectations. The company reduced its revenue dependence on China to 26%, lowering geopolitical ri...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App